Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
Mathieu Jackson, Doctoral Fellow at CHUV | Lausanne university hospital, Board Member of Laboratorio EduCare, shared World Federation of Hemophilia‘s post on LinkedIn:
“It was a great pleasure and source of pride for me to be present at this important event for the global bleeding disorders and hemophilia community.
Adoption of this resolution at WHA79 would greatly help World Federation of Hemophilia advocacy work around the world. Every time new patients are identified and given appropriate comprehensive care, lives are saved.
Many thanks to the supporters and leaders behind this initiative.”
World Federation of Hemophilia (WFH) shared a post on LinkedIn:
“Thank you to all policy-makers, Ministries’ of Health, Geneva Permanent Missions, WHO representatives, bleeding disorders advocates, expert clinicians, industry partners and international civil society actors who have joined us in Geneva for the 79th World Health Assembly Side Event:
‘Advancing Health Equity for Bleeding Disorders‘, as well as many members of our global bleeding disorders community who joined from all over the world online.
Co-Hosted by the World Federation of Hemophilia (WFH), in collaboration with the Ministry of Health of the Republic of Armenia, Rare Diseases International, and the Swiss Haemophilia Society, and co-sponsored by the Ministries of Health and Population of Egypt, Nepal and Sri Lanka, this event offered inspiring opening addresses and two expert panel discussions, underlying the importance of the adoption of the WHA resolution on Global Action to Advance Health Activity for People with Bleeding Disorders Worldwide.
This Resolution is expected to be discussed at the 79th WHA this week, stay tuned for live updates from the WFH!”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’